Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
How do you counsel on the risks of developing anti-drug antibodies when using intrathecal enzyme replacement therapy for lysosomal storage disorders?
Related Questions
How do you decide when to pursue genetic testing for cerebral palsy?
What behavioral interventions have you found most effective for managing self-injurious behavior in autism?
When is the most appropriate time to initiate evaluation for learning disorders following traumatic brain injury in an adolescent?
How would you approach a toddler with alternating head tilt episodes lasting for weeks?
How do pediatric functional neurologic disorders differ from adult disorders in their presentation and diagnosis?
When do you consider cannabidiol for treatment of epilepsy?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
Are there specific tools that you request for an IEP of a child with dyslexia?
How does choice of enzyme replacement therapy and monitoring parameters for late-onset Pompe disease differ from infantile onset disease?
When and how do you perform genetic testing for congenital myasthenia gravis in seronegative cases?
